New Zealand med-tech firm Adherium has gained US Food and Drug Administration (FDA) clearance for over-the-counter sales of its Hailie sensors for athsma and COPD (chronic obstructive pulmonary disease) inhalers.
The ASX-listed company makes health devices such as its Hailie sensor (formerly
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
